SCHEMBL24320128

SCHEMBL24320128

C=Cc1ccc2ncn(-c3ccccn3)c(=O)c2c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IP6K1 Q92551 2/20 0.45
POLB P06746 1/20 0.44
ACVR1 Q04771 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
RAB9A P51151 1/20 0.37
TGFBR1 P36897 2/20 0.36
GAA P10253 1/20 0.36
MAPK1 P28482 1/20 0.36
ESR2 Q92731 1/20 0.36
BMPR1B O00238 1/20 0.35
PDGFRB P09619 1/20 0.35
KIT P10721 1/20 0.35
PDGFRA P16234 1/20 0.35
BMPR1A P36894 1/20 0.35
ACVR1B P36896 1/20 0.35
ACVRL1 P37023 1/20 0.35
MMP13 P45452 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30516952 1.00 IP6K1 (0.45) IP6K1POLBACVR1SMN1; SMN2MEN1
SCHEMBL24320130 0.88 IP6K1 (0.46) IP6K1POLBACVR1SMN1; SMN2MEN1
SCHEMBL30516949 0.88 IP6K1 (0.46) IP6K1POLBACVR1SMN1; SMN2MEN1
SCHEMBL30704943 0.80 POLB (0.48) POLBACVR1SMN1; SMN2MEN1KMT2A
SCHEMBL24320125 0.80 MEN1 (0.52) POLBACVR1SMN1; SMN2MEN1KMT2A
SCHEMBL30656833 0.80 POLB (0.48) POLBACVR1SMN1; SMN2MEN1KMT2A
SCHEMBL24166072 0.80 POLB (0.48) POLBACVR1SMN1; SMN2MEN1KMT2A
SCHEMBL27157404 0.80 POLB (0.48) POLBACVR1SMN1; SMN2MEN1KMT2A
SCHEMBL30516956 0.79 POLB (0.60) POLBACVR1SMN1; SMN2MEN1KMT2A
SCHEMBL8439313 0.79 POLB (0.60) POLBACVR1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081976-A1 PIPERIDINYL SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-04-21 WO disclosed